| 1ADX | A:1-40 | FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, 14 STRUCTURES |
| 1APQ | A:23-75 | STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES |
| 1AUT | L:94-145; L:49-93 | HUMAN ACTIVATED PROTEIN C |
| 1BF9 | A:45-85 | N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES |
| 1C5M | F:0-51 | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
| 1CVW | L:90-144 | CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA) |
| 1DQB | A:1-46; A:47-83 | NMR STRUCTURE OF THROMBOMODULIN EGF(4-5) |
| 1DVA | L:49-85; M:49-85; L:86-142; M:86-142 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA |
| 1DX5 | I:345-389; J:345-389; K:345-389; L:345-389; I:423-462; J:423-462; K:423-462; L:423-462; I:390-422; J:390-422; K:390-422; L:390-422 | CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX |
| 1EZQ | B:0-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515 |
| 1F0R | B:0-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815 |
| 1F0S | B:0-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707 |
| 1F7E | A:45-90 | THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURES |
| 1F7M | A:45-90 | THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTURE |
| 1FAK | L:87-143; L:36-86 | HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT |
| 1FAX | L:85-139 | COAGULATION FACTOR XA INHIBITOR COMPLEX |
| 1FF7 | A:45-90 | THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES |
| 1FFM | A:45-90 | THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE |
| 1FJS | L:87-138 | CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA |
| 1FSB | A:1-40 | STRUCTURE OF THE EGF DOMAIN OF P-SELECTIN, NMR, 19 STRUCTURES |
| 1G1Q | A:120-157; B:120-157; C:120-157; D:120-157 | CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS |
| 1G1R | A:120-157; B:120-157; C:120-157; D:120-157 | CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX |
| 1G1S | A:120-157; B:120-157 | P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE |
| 1G1T | A:120-157 | CRYSTAL STRUCTURE OF E-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX |
| 1G2L | B:251-305 | FACTOR XA INHIBITOR COMPLEX |
| 1G2M | B:385-439 | FACTOR XA INHIBITOR COMPLEX |
| 1HAE | A:1-63 | HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, 20 STRUCTURES |
| 1HAF | A:1-63 | HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE |
| 1HCG | B:1-51 | STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION |
| 1HJ7 | A:334-372; A:293-333 | NMR STUDY OF A PAIR OF LDL RECEPTOR CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 20 STRUCTURES |
| 1HRE | A:175-241 | SOLUTION STRUCTURE OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HEREGULIN-ALPHA, A LIGAND FOR P180ERB4 |
| 1HRF | A:175-241 | SOLUTION STRUCTURE OF THE EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HEREGULIN-ALPHA, A LIGAND FOR P180ERB4 |
| 1HZ8 | A:42-80; A:1-41 | SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR |
| 1I0U | A:42-82; A:1-41 | SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR |
| 1IJQ | A:639-692; B:639-692 | CRYSTAL STRUCTURE OF THE LDL RECEPTOR YWTD-EGF DOMAIN PAIR |
| 1IOE | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55532 |
| 1IOX | A:1-50 | NMR STRUCTURE OF HUMAN BETACELLULIN-2 |
| 1IP0 | A:1-50 | NMR STRUCTURE OF HUMAN BETACELLULIN-2 |
| 1IQE | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55590 |
| 1IQF | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165 |
| 1IQG | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55159 |
| 1IQH | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55143 |
| 1IQI | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55125 |
| 1IQJ | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55124 |
| 1IQK | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55113 |
| 1IQL | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54476 |
| 1IQM | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54471 |
| 1IQN | L:87-137 | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55192 |
| 1IVO | C:5-51; D:5-51 | CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN EPIDERMAL GROWTH FACTOR AND RECEPTOR EXTRACELLULAR DOMAINS. |
| 1J9C | L:89-142; L:48-88 | CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX |
| 1JBU | L:90-143 | COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183 |
| 1JL9 | B:6-50; A:6-47 | CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR |
| 1K36 | A:1-46 | NMR STRUCTURE OF HUMAN EPIREGULIN |
| 1K37 | A:1-46 | NMR STRUCTURE OF HUMAN EPIREGULIN |
| 1KLI | L:84-144 | COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA |
| 1KLJ | L:89-144 | CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA |
| 1KSN | B:-1-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673 |
| 1KYE | | [entry was replaced by entry 3LIW without any CATH domain information] |
| 1L3Y | A:1-41 | INTEGRIN EGF-LIKE MODULE 3 FROM THE BETA-2 SUBUNIT |
| 1LMJ | A:3-88 | NMR STUDY OF THE FIBRILLIN-1 CBEGF12-13 PAIR OF CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS |
| 1LPG | A:1A-50 | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79. |
| 1LPK | A:1A-50 | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125. |
| 1LPZ | A:1A-50 | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41. |
| 1LQD | A:1A-50 | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45. |
| 1MOX | D:3-50; C:2-50 | CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA |
| 1MQ5 | L:87-137 | CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA |
| 1MQ6 | L:87-137 | CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL) AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL) METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA |
| 1N7D | A:333-377; A:295-332; A:643-693 | EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR |
| 1NFU | B:-2-49 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747 |
| 1NFW | B:0-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685 |
| 1NFX | B:-2-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944 |
| 1NFY | B:-2-50 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 |
| 1NQL | B:3-50 | STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN EPIDERMAL GROWTH FACTOR (EGF) RECEPTOR IN AN INACTIVE (LOW PH) COMPLEX WITH EGF. |
| 1NZI | B:118-159; A:118-159 | CRYSTAL STRUCTURE OF THE CUB1-EGF INTERACTION DOMAIN OF COMPLEMENT PROTEASE C1S |
| 1O5D | L:89-142; L:47-88 | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) |
| 1P0S | L:48-129 | CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEX WITH ECOTIN M84R |
| 1P9J | A:1-54 | SOLUTION STRUCTURE AND DYNAMICS OF THE EGF/TGF-ALPHA CHIMERA T1E |
| 1QFK | L:86-144; L:49-85 | STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION |
| 1RFN | B:86-142 | HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE |
| 1SZB | A:126-168; B:126-168 | CRYSTAL STRUCTURE OF THE HUMAN MBL-ASSOCIATED PROTEIN 19 (MAP19) |
| 1TOZ | A:411-453 | NMR STRUCTURE OF THE HUMAN NOTCH-1 LIGAND BINDING REGION |
| 1TPG | A:47-91 | F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE) |
| 1U8C | B:1563-1604; B:1523-1562 | A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE |
| 1URK | A:6-49 | SOLUTION STRUCTURE OF THE AMINO TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR |
| 1UZJ | A:1486-1530; B:2486-2530; C:3486-3530 | INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, HOLO FORM. |
| 1UZK | A:1486-1530 | INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, CA BOUND TO CBEGF23 DOMAIN ONLY |
| 1UZP | A:1486-1530 | INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, SM BOUND FORM CBEGF23 DOMAIN ONLY. |
| 1UZQ | A:1486-1530 | INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, APO FORM CBEGF23 DOMAIN ONLY. |
| 1V3X | B:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE |
| 1W7X | L:90-144 | FACTOR7 - 413 COMPLEX |
| 1W8B | L:88-143 | FACTOR7 - 413 COMPLEX |
| 1WU1 | B:85-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2-YL) SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE |
| 1XFE | A:39-83 | SOLUTION STRUCTURE OF THE LA7-EGFA PAIR FROM THE LDL RECEPTOR |
| 1XKA | L:86-135; L:49-85 | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID |
| 1XKB | A:87-135; B:87-135; A:48-86; B:50-86 | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID |
| 1YGC | L:90-142 | SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR |
| 1YUF | A:1-50 | TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 16 MODELS WITHOUT ENERGY MINIMIZATION |
| 1YUG | A:1-50 | TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 15 MODELS AFTER ECEPP/3 ENERGY MINIMIZATION |
| 1Z6E | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3'-AMINO-1,2-BENZISOXAZOL-5'-YL)-N-(4-(2'-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (RAZAXABAN; DPC906; BMS-561389) |
| 1ZAQ | A:1-44 | FOURTH EGF-LIKE DOMAIN OF THROMBOMODULIN, NMR, 12 STRUCTURES |
| 2ADX | A:1-40 | FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, MINIMIZED AVERAGE STRUCTURE |
| 2B7D | L:89-142; L:49-88 | FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN A BABOON THROMBOSIS MODEL |
| 2BMG | A:-3-50 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50 |
| 2BOH | A:-3-51 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND "1" |
| 2BOK | L:87-138 | FACTOR XA - CATION |
| 2BQ6 | A:1A-49 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21 |
| 2BQ7 | A:-2-49 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43 |
| 2BQW | A:-2-49 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 |
| 2BZ6 | L:90-142 | ORALLY AVAILABLE FACTOR7A INHIBITOR |
| 2CJI | B:-1-50 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2D1J | B:85-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 2-[[4-[(5-CHLOROINDOL-2-YL)SULFONYL]PIPERAZIN-1-YL] CARBONYL]THIENO[3,2-B]PYRIDINE N-OXIDE |
| 2EI6 | B:85-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-CIS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE |
| 2EI7 | B:85-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR TRANS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE |
| 2EI8 | B:85-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-4-(N,N-DIMETHYLCARBAMOYL)-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL) CARBONYL]-1,2-CYCLOHEXANEDIAMINE |
| 2F9B | L:89-142; L:49-88 | DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS |
| 2FD6 | A:11-49 | STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A |
| 2FLB | L:89-142; L:47-88 | DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR |
| 2FLR | L:89-142; L:47-88 | NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS |
| 2FZZ | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE |
| 2G00 | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL)BENZAMIDE |
| 2GD4 | A:87-138; L:86-139 | CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX |
| 2H9E | L:89-136 | CRYSTAL STRUCTURE OF FXA/SELECTIDE/NAPC2 TERNARY COMPLEX |
| 2I9A | B:6-49; A:10-49; D:10-49; C:11-49 | CRYSTAL STRUCTURE OF THE FREE AMINOTERMINAL FRAGMENT OF UROKINASE TYPE PLASMINOGEN ACTIVATOR (ATF) |
| 2I9B | A:11-49; B:11-49; C:11-49; D:11-49 | CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX |
| 2J2U | B:-2-49 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J34 | B:-1-50 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J38 | B:-1-49 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J4I | B:-2-49 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J94 | B:-2-49 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J95 | B:-1-50 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2JKH | L:87-140 | FACTOR XA - CATION INHIBITOR COMPLEX |
| 2P16 | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE |
| 2P3F | L:88-138 | CRYSTAL STRUCTURE OF THE FACTOR XA/NAP5 COMPLEX |
| 2P3T | A:87-138 | CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL-1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4-CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)-6-METHOXY-PHENYL]-AMIDE |
| 2P3U | A:87-137 | CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL) AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE {PFIZER 320663} |
| 2P93 | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE |
| 2P94 | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE |
| 2P95 | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL) THIOPHENE-2-CARBOXAMIDE |
| 2PHB | B:0-50 | AN ORALLY EFFICACIOUS FACTOR XA INHIBITOR |
| 2PR3 | B:1-50 | FACTOR XA INHIBITOR |
| 2PUQ | L:89-142; L:49-88 | CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR |
| 2Q1J | B:0-50 | THE DISCOVERY OF GLYCINE AND RELATED AMINO ACID-BASED FACTOR XA INHIBITORS |
| 2RA0 | L:88-138 | X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE |
| 2TGF | A:1-50 | THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA |
| 2UWL | B:-2-49 | SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA |
| 2UWO | B:-2-49 | SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA |
| 2UWP | B:-2-49 | FACTOR XA INHIBITOR COMPLEX |
| 2VH0 | B:-2-49 | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS |
| 2VH6 | B:-3-50 | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS |
| 2VVC | L:87-138; K:86-139 | AMINOPYRROLIDINE FACTOR XA INHIBITOR |
| 2VVU | L:86-140 | AMINOPYRROLIDINE FACTOR XA INHIBITOR |
| 2VVV | L:87-140 | AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR |
| 2VWL | L:89-139 | AMINOPYRROLIDINE FACTOR XA INHIBITOR |
| 2VWM | L:86-137; K:86-139 | AMINOPYRROLIDINE FACTOR XA INHIBITOR |
| 2VWN | L:88-139 | AMINOPYRROLIDINE FACTOR XA INHIBITOR |
| 2VWO | L:88-139 | AMINOPYRROLIDINE FACTOR XA INHIBITOR |
| 2W26 | B:0A-49 | FACTOR XA IN COMPLEX WITH BAY59-7939 |
| 2W3I | B:0-50 | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2 |
| 2W3K | B:0-50 | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1 |
| 2W86 | A:1-45; A:106-147 | CRYSTAL STRUCTURE OF FIBRILLIN-1 DOMAINS CBEGF9HYB2CBEGF10, CALCIUM SATURATED FORM |
| 2WPH | E:87-145 | FACTOR IXA SUPERACTIVE TRIPLE MUTANT |
| 2WPI | E:87-145 | FACTOR IXA SUPERACTIVE DOUBLE MUTANT |
| 2WPJ | E:87-145 | FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED |
| 2WPK | E:87-145 | FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED |
| 2WPL | E:87-145 | FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED |
| 2WPM | E:87-145 | FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED |
| 2XBV | L:89-139 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 2XBW | L:89-139 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 2XBX | L:89-139 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 2XBY | L:89-139 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 2XC0 | L:89-139 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 2XC4 | L:87-140 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 2XC5 | L:89-139 | FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR |
| 3BT1 | A:8-49 | STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX |
| 3BT2 | A:9-49 | STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX |
| 3CEN | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(2-(((5-CHLORO-2-PYRIDINYL) AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE |
| 3CFW | A:120-156 | L-SELECTIN LECTIN AND EGF DOMAINS |
| 3CS7 | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-METHOXYPHENYL)-6-(4-(1-(PYRROLIDIN-1-YLMETHYL)CYCLOPROPYL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE |
| 3DEM | A:121-164; B:121-164 | CUB1-EGF-CUB2 DOMAIN OF HUMAN MASP-1/3 |
| 3ELA | L:89-142; L:48-88 | CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR |
| 3ENS | A:126-175; C:126-175; A:90-125; C:89-125 | CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH METHYL (2Z)-3-[(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO-3-{[(3S)-2-OXO-1-(2-OXO-2-PYRROLIDIN-1-YLETHYL)AZEPAN-3-YL]AMINO}ACRYLATE |
| 3F1S | B:87-137 | CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR |
| 3FFG | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR (R)-6-(2'-((3-HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4, 5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE |
| 3GIS | Y:348-389; X:349-389; Z:350-389; X:423-463; Y:423-463; Z:423-463; Z:390-422; X:390-422; Y:390-422 | CRYSTAL STRUCTURE OF NA-FREE THROMBIN IN COMPLEX WITH THROMBOMODULIN |
| 3HPT | A:126-175; C:126-175; C:89-125; A:90-125 | CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-2-CYANO-1-(2-METHYLBENZOFURAN-5-YL)-3-(2-OXO-1-(2-OXO-2-(PYRROLIDIN-1-YL)ETHYL) AZEPAN-3-YL)GUANIDINE |
| 3KCG | L:84-137 | CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX |
| 3KL6 | B:-1-48 | DISCOVERY OF TETRAHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVE TAK-442: A POTENT, SELECTIVE AND ORALLY ACTIVE FACTOR XA INHIBITOR |
| 3KQB | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-1H- PYRAZOLE-5-CARBOXAMIDE |
| 3KQC | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 6-(2'- (METHYLSULFONYL) BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL) PHENYL)-3-(TRIFLUOROMETHYL)-5,6- DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE |
| 3KQD | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-(5-OXO-4,5- DIHYDRO-1H-1, 2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1- YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO- 1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE |
| 3KQE | L:87-138 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-METHYL-1-(3-(5- OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'- (PYRROLIDIN-1-YLMETHYL) BIPHENYL-4-YL)-5,6-DIHYDRO-1H- PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE |
| 3LC3 | B:86-142; D:86-142 | BENZOTHIOPHENE INHIBITORS OF FACTOR IXA |
| 3LC5 | B:86-139 | SELECTIVE BENZOTHIOPHINE INHIBITORS OF FACTOR IXA |
| 3TGF | A:1-50 | THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA |
| 4TGF | A:1-50 | SOLUTION STRUCTURES OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA DERIVED FROM 1*H NMR DATA |
)
)